US Patent 11026860 Method and device for optical ophthalmic therapy
Patent 11026860 was granted and assigned to IRIDEX Corporation on June, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11026860 Method and device for optical ophthalmic therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.